{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:24:04Z","timestamp":1793863444966,"version":"4.6.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81802564"],"award-info":[{"award-number":["81802564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81874203"],"award-info":[{"award-number":["81874203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81772744"],"award-info":[{"award-number":["81772744"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972374"],"award-info":[{"award-number":["81972374"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902612"],"award-info":[{"award-number":["81902612"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation Grant","doi-asserted-by":"crossref","award":["2018M632489"],"award-info":[{"award-number":["2018M632489"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang Province Medical and Health Scientific Research Project","award":["2019RC033"],"award-info":[{"award-number":["2019RC033"]}]},{"name":"2018 Zhejiang University Academic Award for Outstanding Doctoral Candidates","id":[{"id":"https:\/\/ror.org\/00a2xv884","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY20H160022"],"award-info":[{"award-number":["LY20H160022"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      N6-methyladenosine (m\n                      <jats:sup>6<\/jats:sup>\n                      A) is the most abundant modification in mRNA of humans. Emerging evidence has supported the fact that m\n                      <jats:sup>6<\/jats:sup>\n                      A is comprehensively involved in various diseases especially cancers. As a crucial reader, YTHDF2 usually mediates the degradation of m\n                      <jats:sup>6<\/jats:sup>\n                      A-modified mRNAs in m\n                      <jats:sup>6<\/jats:sup>\n                      A-dependent way. However, the function and mechanisms of m\n                      <jats:sup>6<\/jats:sup>\n                      A especially YTHDF2 in prostate cancer (PCa) still remain elusive.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      To investigate the functions and mechanisms of YTHDF2 in PCa, in vitro\n                      <jats:italic>,<\/jats:italic>\n                      in vivo biofunctional assays and epigenetics experiments were performed. Endogenous expression silencing of YTHDF2 and METTL3 was established with lentivirus-based shRNA technique. Colony formation, flow cytometry and trans-well assays were performed for cell function identifications. Subcutaneous xenografts and metastatic mice models were combined with in vivo imaging system to investigate the phenotypes when knocking down YTHDF2 and METTL3. m\n                      <jats:sup>6<\/jats:sup>\n                      A RNA immunoprecipitation (MeRIP) sequencing, mRNA sequencing, RIP-RT-qPCR and bioinformatics analysis were mainly used to screen and validate the direct common targets of YTHDF2 and METTL3. In addition, TCGA database was also used to analyze the expression pattern of YTHDF2, METTL3 and the common target LHPP in PCa, and their correlation with clinical prognosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The upregulated YTHDF2 and METTL3 in PCa predicted a worse overall survival rate. Knocking down YTHDF2 or METTL3 markedly inhibited the proliferation and migration of PCa in vivo and in vitro. LHPP and NKX3\u20131 were identified as the direct targets of both YTHDF2 and METTL3. YTHDF2 directly bound to the m\n                      <jats:sup>6<\/jats:sup>\n                      A modification sites of LHPP and NKX3\u20131 to mediate the mRNA degradation. Knock-down of YTHDF2 or METTL3 significantly induced the expression of LHPP and NKX3\u20131 at both mRNA and protein level with inhibited phosphorylated AKT. Overexpression of LHPP and NKX3\u20131 presented the consistent phenotypes and AKT phosphorylation inhibition with knock-down of YTHDF2 or METTL3. Phosphorylated AKT was consequently confirmed as the downstream of METTL3\/YTHDF2\/LHPP\/NKX3\u20131 to induce tumor proliferation and migration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      We propose a novel regulatory mechanism in which YTHDF2 mediates the mRNA degradation of the tumor suppressors LHPP and NKX3\u20131 in m\n                      <jats:sup>6<\/jats:sup>\n                      A-dependent way to regulate AKT phosphorylation-induced tumor progression in prostate cancer. We hope our findings may provide new concepts of PCa biology.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12943-020-01267-6","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T09:03:09Z","timestamp":1603962189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":265,"title":["YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Jiangfeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liujia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"key":"1267_CR1","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1101\/gad.262766.115","volume":"29","author":"Y Yue","year":"2015","unstructured":"Yue Y, Liu J, He C. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev. 2015;29:1343\u201355.","journal-title":"Genes Dev"},{"key":"1267_CR2","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.aau1646","volume":"361","author":"M Frye","year":"2018","unstructured":"Frye M, Harada BT. RNA modifications modulate gene expression during development. Science. 2018;361:1346\u20139.","journal-title":"Science"},{"key":"1267_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"XL Ping","year":"2014","unstructured":"Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ, Adhikari S, Shi Y, Lv Y, Chen YS. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24:177.","journal-title":"Cell Res"},{"key":"1267_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, Jia G, Yu M, Lu Z, Deng X. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93\u20135.","journal-title":"Nat Chem Biol"},{"key":"1267_CR5","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, Weng X, Chen K, Shi H, He C. N6-methyladenosine modulates messenger RNA translation efficiency. Cell. 2015;161:1388\u201399.","journal-title":"Cell"},{"key":"1267_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","volume":"61","author":"W Xiao","year":"2016","unstructured":"Xiao W, Adhikari S, Dahal U, Chen YS, Hao YJ, Sun BF, Sun HY, Li A, Ping XL, Lai WY. Nuclear m (6) a reader YTHDC1 regulates mRNA splicing. Mol Cell. 2016;61:507\u201319.","journal-title":"Mol Cell"},{"key":"1267_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, Fu Y, Parisien M, Dai Q, Jia G. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117\u201320.","journal-title":"Nature"},{"key":"1267_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/cr.2017.15","volume":"27","author":"H Shi","year":"2017","unstructured":"Shi H, Xiao W, Lu Z, Zhao BS, Ma H, Hsu PJ, Chang L, He C. YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. Cell Res. 2017;27:315\u201328.","journal-title":"Cell Res"},{"key":"1267_CR9","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","volume":"162","author":"CR Alarc\u00f3n","year":"2015","unstructured":"Alarc\u00f3n CR, Goodarzi H, Lee H, Liu X, Tavazoie S, Tavazoie SF. HNRNPA2B1 is a mediator of m (6) A-dependent nuclear RNA processing events. Cell. 2015;162:1299\u2013308.","journal-title":"Cell"},{"key":"1267_CR10","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.1073\/pnas.1721371115","volume":"115","author":"JM Fustin","year":"2018","unstructured":"Fustin JM, Kojima R, Itoh K, Chang HY, Shiqi Y, Zhuang B, Oji A, Gibo S, Narasimamurthy R, Virshup D. Two Ck1\u03b4 transcripts regulated by m6A methylation code for two antagonistic kinases in the control of the circadian clock. Proc Natl Acad Sci U S A. 2018;115:5980.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1267_CR11","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/cr.2017.100","volume":"27","author":"K Xu","year":"2017","unstructured":"Xu K, Yang Y, Feng GH, Sun BF, Chen JQ, Li YF, Chen YS, Zhang XX, Wang CX, Jiang LY. Mettl3-mediated m6A regulates spermatogonial differentiation and meiosis initiation. Cell Res. 2017;27:1100.","journal-title":"Cell Res"},{"key":"1267_CR12","doi-asserted-by":"publisher","first-page":"4630","DOI":"10.1111\/jcmm.13804","volume":"22","author":"L He","year":"2018","unstructured":"He L, Li J, Wang X, Ying Y, Xie H, Yan H, Zheng X, Xie L. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers. J Cell Mol Med. 2018;22:4630.","journal-title":"J Cell Mol Med"},{"key":"1267_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ajur.2017.11.004","volume":"5","author":"L Xie","year":"2018","unstructured":"Xie L, Li J, Wang X. Updates in Prostate Cancer Detections and Treatments-Messages from 2017 EAU and AUA \u2606. Asian J Urol. 2018;5:3\u20137.","journal-title":"Asian J Urol"},{"key":"1267_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41419-017-0129-x","volume":"9","author":"D Dai","year":"2018","unstructured":"Dai D, Wang H, Zhu L, Jin H, Wang X. N6-methyladenosine links RNA metabolism to cancer progression. Cell Death Dis. 2018;9:124.","journal-title":"Cell Death Dis"},{"key":"1267_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12943-018-0847-4","volume":"17","author":"S Wang","year":"2018","unstructured":"Wang S, Chai P, Jia R, Jia R. Novel insights on m6A RNA methylation in tumorigenesis: a double-edged sword. Mol Cancer. 2018;17:101.","journal-title":"Mol Cancer"},{"key":"1267_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13804","volume-title":"The dual role of N6-methyladenosine modification of RNAs is involved in human cancers","author":"L He","year":"2018","unstructured":"He L, Li J, Wang X, Ying Y, Xie H, Yan H, Zheng X. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers; 2018."},{"key":"1267_CR17","doi-asserted-by":"publisher","first-page":"12626","DOI":"10.1038\/ncomms12626","volume":"7","author":"H Du","year":"2016","unstructured":"Du H, Zhao Y, He J, Zhang Y, Xi H, Liu M, Ma J, Wu L. YTHDF2 destabilizes m (6) A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat Commun. 2016;7:12626.","journal-title":"Nat Commun"},{"key":"1267_CR18","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1074\/jbc.M116.749689","volume":"292","author":"Z Yang","year":"2017","unstructured":"Yang Z, Li J, Feng G, Gao S, Wang Y, Zhang S, Liu Y, Ye L, Li Y, Zhang X. MicroRNA-145 modulates N6 methyladenosine levels by targeting the 3\u2032 Untranslated mRNA region of the N6-methyladenosine binding YTH domain family 2 protein. J Biol Chem. 2017;292:3614.","journal-title":"J Biol Chem"},{"key":"1267_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-018-0082-y","volume-title":"Loss of YTHDF2-mediated m 6 A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration","author":"H Wang","year":"2018","unstructured":"Wang H, Zuo H, Liu J, Wen F, Gao Y, Zhu X, Liu B, Xiao F, Wang W, Huang G. Loss of YTHDF2-mediated m 6 A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration; 2018."},{"key":"1267_CR20","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67:2254.","journal-title":"Hepatology"},{"key":"1267_CR21","doi-asserted-by":"publisher","first-page":"e3010","DOI":"10.1038\/cddis.2017.331","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Xu X, Meng S, Liang Z, Wang X, Xu M, Wang S, Li S, Zhu Y, Xie B. MET\/SMAD3\/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer. Cell Death Dis. 2017;8:e3010.","journal-title":"Cell Death Dis"},{"key":"1267_CR22","volume-title":"Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer","author":"J Li","year":"2018","unstructured":"Li J, Ying Y, Xie H, Jin K, Yan H, Wang S, Xu M, Xu X, Wang X, Yang K. Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer; 2018."},{"key":"1267_CR23","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.18632\/oncotarget.23365","volume":"9","author":"J Li","year":"2018","unstructured":"Li J, Meng S, Xu M, Wang S, He L, Xu X, Wang X, Xie L. Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels. Oncotarget. 2018;9:3752\u201364.","journal-title":"Oncotarget"},{"key":"1267_CR24","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/cr.2014.152","volume":"24","author":"T Zhu","year":"2014","unstructured":"Zhu T, Roundtree IA, Wang P, Wang X, Wang L, Sun C, Tian Y, Li J, He C, Xu Y. Crystal structure of the YTH domain of YTHDF2 reveals mechanism for recognition of N6-methyladenosine. Cell Res. 2014;24:1493\u20136.","journal-title":"Cell Res"},{"key":"1267_CR25","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2017","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2017;46:D956.","journal-title":"Nucleic Acids Res"},{"key":"1267_CR26","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nature26140","volume":"555","author":"SK Hindupur","year":"2018","unstructured":"Hindupur SK, Colombi M, Fuhs SR, Matter MS, Guri Y, Adam K, Cornu M, Piscuoglio S, Ng C, Betz C. The protein histidine phosphatase LHPP is a tumour suppressor. Nature. 2018;555:678.","journal-title":"Nature"},{"key":"1267_CR27","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.bbrc.2018.06.127","volume":"503","author":"J Zheng","year":"2018","unstructured":"Zheng J, Dai X, Chen H, Fang C, Chen J, Sun L. Down-regulation of LHPP in cervical cancer influences cell proliferation, metastasis and apoptosis by modulating AKT. Biochem Biophys Res Commun. 2018;503:1108.","journal-title":"Biochem Biophys Res Commun"},{"key":"1267_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"d W Huang","year":"2009","unstructured":"Huang d W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357.","journal-title":"Nat Protoc"},{"key":"1267_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"d W Huang","year":"2009","unstructured":"Huang d W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1\u201313.","journal-title":"Nucleic Acids Res"},{"key":"1267_CR30","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1093\/nar\/gkw104","volume":"44","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44:e91.","journal-title":"Nucleic Acids Res"},{"key":"1267_CR31","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1073\/pnas.042688999","volume":"99","author":"MJ Kim","year":"2002","unstructured":"Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, Shen MM, Abate-Shen C, Kim MJ, et al. Cooperativity of Nkx3. 1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc. Natl Acad. Sci. USA 99, 2884\u20132889. Proc Natl Acad Sci. 2002;99:2884\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"1267_CR32","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1128\/MCB.22.5.1495-1503.2002","volume":"22","author":"SA Abdulkadir","year":"2002","unstructured":"Abdulkadir SA, Magee JA, Peters TJ, Kaleem Z, Naughton CK, Humphrey PA, Milbrandt J. Conditional Loss of Nkx3.1 in Adult Mice Induces Prostatic Intraepithelial Neoplasia. Mol Cell Biol. 2002;22:1495.","journal-title":"Mol Cell Biol"},{"key":"1267_CR33","first-page":"6111","volume":"60","author":"B Cai","year":"2000","unstructured":"Cai B, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression1,2. Cancer Res. 2000;60:6111.","journal-title":"Cancer Res"},{"key":"1267_CR34","first-page":"795","volume":"5","author":"T Eide","year":"2013","unstructured":"Eide T, Task\u00e9n KA, Tindall D. TWIST, A NOVEL ANDROGEN-REGULATED GENE IS A TARGET FOR NKX3.1 IN PROSTATE CANCER CELLS. Cancer Cell Int,13,1(2013-01-31). 2013;5:795.","journal-title":"Cancer Cell Int,13,1(2013-01-31)"},{"key":"1267_CR35","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/pros.22709","volume":"73","author":"S Ren","year":"2013","unstructured":"Ren S, Kang MR, Wang J, Huang V, Place RF, Sun Y, Li LC. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth. Prostate. 2013;73:1591\u2013601.","journal-title":"Prostate"},{"key":"1267_CR36","doi-asserted-by":"publisher","first-page":"e109868","DOI":"10.1371\/journal.pone.0109868","volume":"9","author":"B Debelecbutuner","year":"2014","unstructured":"Debelecbutuner B, Alapinar C, Ertunc N, Gonenkorkmaz C, Y\u00f6r\u00fcko\u011flu K, Korkmaz KS. TNF\u03b1-Mediated Loss of \u03b2-Catenin\/E-Cadherin Association and Subsequent Increase in Cell Migration Is Partially Restored by NKX3.1 Expression in Prostate Cells. PLoS One. 2014;9:e109868.","journal-title":"PLoS One"},{"key":"1267_CR37","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1158\/0008-5472.CAN-08-3022","volume":"69","author":"E Muhlbradt","year":"2009","unstructured":"Muhlbradt E, Asatiani E, Ortner E, Wang A, Gelmann EP. NKX3.1 activates expression of insulin-like growth factor binding protein-3 to mediate insulin-like growth factor-I signaling and cell proliferation. Cancer Res. 2009;69:2615\u201322.","journal-title":"Cancer Res"},{"key":"1267_CR38","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1038\/onc.2009.181","volume":"28","author":"H Song","year":"2009","unstructured":"Song H, Zhang B, Watson MA, Humphrey PA, Lim H, Milbrandt J. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Oncogene. 2009;28:3307.","journal-title":"Oncogene"},{"key":"1267_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13059-018-1436-y","volume":"19","author":"M Li","year":"2018","unstructured":"Li M, Zhao X, Wang W, Shi H, Pan Q, Lu Z, Perez SP, Suganthan R, He C, Bj\u00f8r\u00e5s M. Ythdf2-mediated m6A mRNA clearance modulates neural development in mice. Genome Biol. 2018;19:69.","journal-title":"Genome Biol"},{"key":"1267_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cr.2014.162","volume":"25","author":"MS Ben-Haim","year":"2014","unstructured":"Ben-Haim MS, Moshitch-Moshkovitz S, Rechavi G. FTO-dependent m (6) a demethylation regulates adipogenesis. Cell Res. 2014;25:3.","journal-title":"Cell Res"},{"key":"1267_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12943-019-1082-3","volume":"18","author":"J Hou","year":"2019","unstructured":"Hou J, Zhang H, Liu J, Zhao Z, Wang J, Lu Z, Hu B, Zhou J, Zhao Z, Feng M, et al. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Mol Cancer. 2019;18:163.","journal-title":"Mol Cancer"},{"key":"1267_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","volume":"25","author":"J Paris","year":"2019","unstructured":"Paris J, Morgan M, Campos J, Spencer GJ, Shmakova A, Ivanova I, Mapperley C, Lawson H, Wotherspoon DA, Sepulveda C, et al. Targeting the RNA m (6) A Reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia. Cell Stem Cell. 2019;25:137\u2013148.e136.","journal-title":"Cell Stem Cell"},{"key":"1267_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ccr.2006.03.031","volume":"9","author":"Q Lei","year":"2006","unstructured":"Lei Q, Jiao J, Xin L, Chang CJ, Wang S, Gao J, Gleave ME, Witte ON, Liu X, Wu H. NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss. Cancer Cell. 2006;9:367\u201378.","journal-title":"Cancer Cell"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-020-01267-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12943-020-01267-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-020-01267-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T01:09:01Z","timestamp":1604192941000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-020-01267-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,29]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1267"],"URL":"https:\/\/doi.org\/10.1186\/s12943-020-01267-6","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,29]]},"assertion":[{"value":"17 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed on the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}